Chie Suzuki Selected Research

RS-1269

10/2010

A novel CC chemokine receptor 4 antagonist RS-1269 inhibits ovalbumin-induced ear swelling and lipopolysaccharide-induced endotoxic shock in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chie Suzuki Research Topics

Disease

10	Neoplasms (Cancer) 01/2019 - 11/2003
5	Lung Neoplasms (Lung Cancer) 02/2007 - 11/2003
2	Edema (Dropsy) 08/2007 - 01/2007
2	Carcinogenesis 12/2005 - 11/2003
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2022
1	Sideroblastic Anemia 01/2022
1	X-linked sideroblastic anemia 01/2022
1	Atherosclerotic Plaque (Atheroma) 11/2021
1	Neuroinflammatory Diseases 01/2021
1	Hyperalgesia 01/2020
1	Inflammation (Inflammations) 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019
1	T-Cell Leukemia (Leukemia, T Cell) 01/2019
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2019
1	Multiple Myeloma 01/2019
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Residual Neoplasm 01/2019
1	Leukemia 01/2019
1	Cysts 01/2017
1	Acanthamoeba Keratitis 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2015
1	Shock 10/2010
1	Necrosis 10/2010
1	Atopic Dermatitis (Atopic Eczema) 10/2010

Drug/Important Bio-Agent (IBA)

5	AcidsIBA 01/2020 - 08/2013
4	wogoninIBA 05/2011 - 01/2007
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 11/2015 - 05/2015
2	protoporphyrin IXIBA 10/2014 - 08/2013
2	Etoposide (VP 16)FDA LinkGeneric 05/2011 - 01/2007
2	Antineoplastic Agents (Antineoplastics)IBA 05/2011 - 01/2007
2	flavoneIBA 08/2007 - 01/2007
2	CarrageenanIBA 08/2007 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 02/2007 - 11/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2022
1	5-Aminolevulinate SynthetaseIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 11/2021
1	ApolipoproteinsIBA 11/2021
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2021
1	resolvin D1IBA 01/2020
1	docosahexaenoylascorbic acid (DHA-As)IBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Freund's AdjuvantIBA 01/2020
1	LipidsIBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 01/2019
1	PorphyrinsIBA 01/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	EnzymesIBA 01/2018
1	SolutionsIBA 01/2017
1	Butyric Acid (Butanoic Acid)IBA 11/2015
1	BuffersIBA 11/2015
1	SodiumIBA 11/2015
1	deoxyuridine triphosphateIBA 05/2015
1	isobutyric acidIBA 05/2015
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2015
1	fluorexon (calcein)IBA 05/2011
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2011
1	OvalbuminIBA 10/2010
1	LipopolysaccharidesIBA 10/2010
1	CCR4 ReceptorsIBA 10/2010
1	RS-1269IBA 10/2010
1	Phosphotransferases (Kinase)IBA 02/2007
1	Surface-Active Agents (Surfactants)IBA 01/2007
1	Fluorouracil (Carac)FDA LinkGeneric 01/2007
1	Cisplatin (Platino)FDA LinkGeneric 01/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2007
1	neuromedin UIBA 10/2006
1	Ghrelin ReceptorsIBA 10/2006
1	Complementary DNA (cDNA)IBA 10/2006
1	Neurotensin Receptors (Neurotensin Receptor)IBA 10/2006
1	anillinIBA 12/2005
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2005
1	Indicators and Reagents (Reagents)IBA 12/2005
1	Microfilament Proteins (Actin Binding Proteins)IBA 12/2005
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2003
1	OligonucleotidesIBA 11/2003

Therapy/Procedure

4	Therapeutics 01/2019 - 11/2003
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2017
1	Radiotherapy 05/2015
1	Oral Administration 10/2010